Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1

Clinical Immunology

Volumn 99, Issue 3, 2001, Pages 325-333

  Tada, Yoshifumi ^a   Ho, Alexandra ^b   Koarada, Syuichi ^a   Morito, Fumitaka ^a   Ushiyama, Osamu ^a   Suzuki, Noriaki ^a   Kikuchi, Yuji ^a   Ohta, Akihide ^a   Mak, Tak W ^b   Nagasawa, Kohei ^a  

^a SAGA UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Arthritis; TNF; TNF receptor

Indexed keywords

COLLAGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTHRITIS; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNE SYSTEM; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0035020551     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5027     Document Type: Article

References (63)

1. Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis
2. Localization of tumor necrosis factor a in synivial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis
3. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints
4. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis
5. DBA/1 mice expressing the human TNF-α transgene develop a severe, erosive arthritis: Characterization of the cytokine cascade and cellular composition
6. Acceleration of onset of collagen-induced arthritis by intraarticular injection of tumour necrosis factor or transforming growth factor-beta
7. Involvement of endogenous tumor necrosis factor a and transforming growth factor β during induction of collagen type II arthritis in mice
8. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis
9. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor
10. Influence of a recombinant human soluble tumor necrosis factor receptor Fc fusion protein on type II collagen-induced arthritis in mice
11. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
12. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis
13. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
14. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
15. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor and p75 receptor-selective TNF-α mutants
16. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: Identification of a novel in vivo role for p75
17. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L, monocytogenes infection
18. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
19. The receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
20. Critical role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration
21. Decreased sensitibity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice
22. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor α
23. Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75
24. Role of the 75-kDa TNF receptor in TNF-induced activation of neutrophile respiratory burst
25. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor
26. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells
27. Induction of apoptosis in mature T cells by tumour necrosis factor
28. TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1
29. Role of the 75-kDa tumor necrosis factor receptor: Inhibition of early hematopoiesis
30. + T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis
31. CD28-deficient mice are highly resistant to collagen-induced arthritis
32. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor
33. Different roles of TNFα and IL-1 in murine streptococcal cell wall arthritis
34. IL-1αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation
35. Overexpression of the p80 receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation, and c-Jun kinase activation
36. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice
37. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
38. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
39. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice
40. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1αβ, and IL-1Ra
41. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice
42. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee
43. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: Comparison of efficacy in animal models with human clinical data
44. Interleukin 6 is required for the development of collagen-induced arthritis
45. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice
46. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA)
47. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice
48. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin
49. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1
50. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis
51. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
52. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
53. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins
54. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis
55. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
56. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex: Reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis
57. Role of tumor necrosis factor-α in the regulation of activated synovial T cell growth: Down-regulation of synovial T cells in rheumatoid arthritis patients
58. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies
59. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints
60. Both tumor necrosis receptor types mediate proliferative signals in human mononuclear cell activation
61. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma
62. L on activated T cells and can be prevented by CD28 costiumlation
63. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor